{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T14:44:03Z","timestamp":1769525043167,"version":"3.49.0"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,11,4]]},"DOI":"10.7759\/cureus.72993","type":"journal-article","created":{"date-parts":[[2024,11,4]],"date-time":"2024-11-04T16:38:12Z","timestamp":1730738292000},"source":"Crossref","is-referenced-by-count":1,"title":["Effects of Concomitant Use of Various Psychotropic Medications on the Treatment Response to Transcranial Magnetic Stimulation for Depression: A Literature Review"],"prefix":"10.7759","author":[{"given":"Jordan","family":"Intrator","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jack","family":"Noto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Renzmark D","family":"Vallesteros","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Morgan","family":"Peltier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John","family":"O'Reardon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muhammad","family":"Abbas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1001\/jamapsychiatry.2017.4602","article-title":"Epidemiology of adult DSM-5 major depressive disorder and its specifiers in the United States","volume":"75","author":"Hasin DS","year":"2018","unstructured":"Hasin DS, Sarvet AL, Meyers JL, Saha TD, Ruan WJ, Stohl M, Grant BF. Epidemiology of adult DSM-5 major depressive disorder and its specifiers in the United States. JAMA Psychiatry. 2018, 75:336-46. 10.1001\/jamapsychiatry.2017.4602","journal-title":"JAMA Psychiatry"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1002\/da.22968","article-title":"Defining treatment-resistant depression","volume":"37","author":"Gaynes BN","year":"2020","unstructured":"Gaynes BN, Lux L, Gartlehner G, et al.. Defining treatment-resistant depression. Depress Anxiety. 2020, 37:134-45. 10.1002\/da.22968","journal-title":"Depress Anxiety"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.2006.163.11.1905","article-title":"Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report","volume":"163","author":"Rush AJ","year":"2006","unstructured":"Rush AJ, Trivedi MH, Wisniewski SR, et al.. Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report. Am J Psychiatry. 2006, 163:1905-17. 10.1176\/ajp.2006.163.11.1905","journal-title":"Am J Psychiatry"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.163.1.28","article-title":"Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: implications for clinical practice","volume":"163","author":"Trivedi MH","year":"2006","unstructured":"Trivedi MH, Rush AJ, Wisniewski SR, et al.. Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: implications for clinical practice. Am J Psychiatry. 2006, 163:28-40. 10.1176\/appi.ajp.163.1.28","journal-title":"Am J Psychiatry"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopsych.2007.01.018","article-title":"Efficacy and safety of transcranial magnetic stimulation in the acute treatment of major depression: a multisite randomized controlled trial","volume":"62","author":"O'Reardon JP","year":"2007","unstructured":"O'Reardon JP, Solvason HB, Janicak PG, et al.. Efficacy and safety of transcranial magnetic stimulation in the acute treatment of major depression: a multisite randomized controlled trial. Biol Psychiatry. 2007, 62:1208-16. 10.1016\/j.biopsych.2007.01.018","journal-title":"Biol Psychiatry"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1001\/archgenpsychiatry.2010.46","article-title":"Daily left prefrontal transcranial magnetic stimulation therapy for major depressive disorder: a sham-controlled randomized trial","volume":"67","author":"George MS","year":"2010","unstructured":"George MS, Lisanby SH, Avery D, et al.. Daily left prefrontal transcranial magnetic stimulation therapy for major depressive disorder: a sham-controlled randomized trial. Arch Gen Psychiatry. 2010, 67:507-16. 10.1001\/archgenpsychiatry.2010.46","journal-title":"Arch Gen Psychiatry"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.jad.2019.04.067","article-title":"The effect of psychotropic drugs on cortical excitability and plasticity measured with transcranial magnetic stimulation: Implications for psychiatric treatment","volume":"253","author":"Minzenberg MJ","year":"2019","unstructured":"Minzenberg MJ, Leuchter AF. The effect of psychotropic drugs on cortical excitability and plasticity measured with transcranial magnetic stimulation: Implications for psychiatric treatment. J Affect Disord. 2019, 253:126-40. 10.1016\/j.jad.2019.04.067","journal-title":"J Affect Disord"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1097\/YCT.0b013e3181ce1a8c","article-title":"Safety, tolerability, and effectiveness of high doses of adjunctive daily left prefrontal repetitive transcranial magnetic stimulation for treatment-resistant depression in a clinical setting","volume":"27","author":"Hadley D","year":"2011","unstructured":"Hadley D, Anderson BS, Borckardt JJ, Arana A, Li X, Nahas Z, George MS. Safety, tolerability, and effectiveness of high doses of adjunctive daily left prefrontal repetitive transcranial magnetic stimulation for treatment-resistant depression in a clinical setting. J ECT. 2011, 27:18-25. 10.1097\/YCT.0b013e3181ce1a8c","journal-title":"J ECT"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1097\/YCO.0b013e32835ab46d","article-title":"The expanding evidence base for rTMS treatment of depression","volume":"26","author":"George MS","year":"2013","unstructured":"George MS, Taylor JJ, Short EB. The expanding evidence base for rTMS treatment of depression. Curr Opin Psychiatry. 2013, 26:13-8. 10.1097\/YCO.0b013e32835ab46d","journal-title":"Curr Opin Psychiatry"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1017\/S0033291713000512","article-title":"Response, remission and drop-out rates following high-frequency repetitive transcranial magnetic stimulation (rTMS) for treating major depression: a systematic review and meta-analysis of randomized, double-blind and sham-controlled trials","volume":"44","author":"Berlim MT","year":"2014","unstructured":"Berlim MT, van den Eynde F, Tovar-Perdomo S, Daskalakis ZJ. Response, remission and drop-out rates following high-frequency repetitive transcranial magnetic stimulation (rTMS) for treating major depression: a systematic review and meta-analysis of randomized, double-blind and sham-controlled trials. Psychol Med. 2014, 44:225-39. 10.1017\/S0033291713000512","journal-title":"Psychol Med"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.16cs10905","article-title":"Consensus recommendations for the clinical application of repetitive transcranial magnetic stimulation (rTMS) in the treatment of depression","volume":"79","author":"McClintock SM","year":"2018","unstructured":"McClintock SM, Reti IM, Carpenter LL, et al.. Consensus recommendations for the clinical application of repetitive transcranial magnetic stimulation (rTMS) in the treatment of depression. J Clin Psychiatry. 2018, 79:16cs10905. 10.4088\/JCP.16cs10905","journal-title":"J Clin Psychiatry"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.psychres.2020.113287","article-title":"Effect of psychotropic drugs on cortical excitability of patients with major depressive disorders: A transcranial magnetic stimulation study","volume":"291","author":"Khedr EM","year":"2020","unstructured":"Khedr EM, Elserogy Y, Fawzy M, Abdelrahman AA, Galal AM, Noaman MM. Effect of psychotropic drugs on cortical excitability of patients with major depressive disorders: A transcranial magnetic stimulation study. Psychiatry Res. 2020, 291:113287. 10.1016\/j.psychres.2020.113287","journal-title":"Psychiatry Res"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinph.2014.08.028","article-title":"TMS and drugs revisited 2014","volume":"126","author":"Ziemann U","year":"2015","unstructured":"Ziemann U, Reis J, Schwenkreis P, Rosanova M, Strafella A, Badawy R, M\u00fcller-Dahlhaus F. TMS and drugs revisited 2014. Clin Neurophysiol. 2015, 126:1847-68. 10.1016\/j.clinph.2014.08.028","journal-title":"Clin Neurophysiol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuropharm.2012.03.023","article-title":"Lithium: a switch from LTD- to LTP-like plasticity in human cortex","volume":"63","author":"Voytovych H","year":"2012","unstructured":"Voytovych H, Kriv\u00e1nekov\u00e1 L, Ziemann U. Lithium: a switch from LTD- to LTP-like plasticity in human cortex. Neuropharmacology. 2012, 63:274-9. 10.1016\/j.neuropharm.2012.03.023","journal-title":"Neuropharmacology"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinph.2012.05.011","article-title":"Effects of lamotrigine on human motor cortex plasticity","volume":"124","author":"Delvendahl I","year":"2013","unstructured":"Delvendahl I, Lindemann H, Heidegger T, Normann C, Ziemann U, Mall V. Effects of lamotrigine on human motor cortex plasticity. Clin Neurophysiol. 2013, 124:148-53. 10.1016\/j.clinph.2012.05.011","journal-title":"Clin Neurophysiol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.26355\/eurrev_201802_14321","article-title":"TMS as tool to investigate the effect of pharmacological medications on cortical plasticity","volume":"22","author":"Caipa A","year":"2018","unstructured":"Caipa A, Alomar M, Bashir S. TMS as tool to investigate the effect of pharmacological medications on cortical plasticity. Eur Rev Med Pharmacol Sci. 2018, 22:844-52. 10.26355\/eurrev_201802_14321","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/j.brs.2009.10.005","article-title":"Physiology of repetitive transcranial magnetic stimulation of the human brain","volume":"3","author":"Hoogendam JM","year":"2010","unstructured":"Hoogendam JM, Ramakers GM, Di Lazzaro V. Physiology of repetitive transcranial magnetic stimulation of the human brain. Brain Stimul. 2010, 3:95-118. 10.1016\/j.brs.2009.10.005","journal-title":"Brain Stimul"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.3390\/brainsci12070929","article-title":"Evidence of neuroplastic changes after transcranial magnetic, electric, and deep brain stimulation","volume":"12","author":"Kricheldorff J","year":"2022","unstructured":"Kricheldorff J, G\u00f6ke K, Kiebs M, Kasten FH, Herrmann CS, Witt K, Hurlemann R. Evidence of neuroplastic changes after transcranial magnetic, electric, and deep brain stimulation. Brain Sci. 2022, 12:929. 10.3390\/brainsci12070929","journal-title":"Brain Sci"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1113\/JP273137","article-title":"Acute and chronic effects of noradrenergic enhancement on transcranial direct current stimulation-induced neuroplasticity in humans","volume":"595","author":"Kuo HI","year":"2017","unstructured":"Kuo HI, Paulus W, Batsikadze G, Jamil A, Kuo MF, Nitsche MA. Acute and chronic effects of noradrenergic enhancement on transcranial direct current stimulation-induced neuroplasticity in humans. J Physiol. 2017, 595:1305-14. 10.1113\/JP273137","journal-title":"J Physiol"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1038\/npp.2015.270","article-title":"Chronic enhancement of serotonin facilitates excitatory transcranial direct current stimulation-induced neuroplasticity","volume":"41","author":"Kuo HI","year":"2016","unstructured":"Kuo HI, Paulus W, Batsikadze G, Jamil A, Kuo MF, Nitsche MA. Chronic enhancement of serotonin facilitates excitatory transcranial direct current stimulation-induced neuroplasticity. Neuropsychopharmacology. 2016, 41:1223-30. 10.1038\/npp.2015.270","journal-title":"Neuropsychopharmacology"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1038\/npp.2011.100","article-title":"D2 receptor block abolishes \u03b8 burst stimulation-induced neuroplasticity in the human motor cortex","volume":"36","author":"Monte-Silva K","year":"2011","unstructured":"Monte-Silva K, Ruge D, Teo JT, Paulus W, Rothwell JC, Nitsche MA. D2 receptor block abolishes \u03b8 burst stimulation-induced neuroplasticity in the human motor cortex. Neuropsychopharmacology. 2011, 36:2097-102. 10.1038\/npp.2011.100","journal-title":"Neuropsychopharmacology"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1016\/j.jad.2023.01.070","article-title":"Real world transcranial magnetic stimulation for major depression: A multisite, naturalistic, retrospective study","volume":"326","author":"Bouaziz N","year":"2023","unstructured":"Bouaziz N, Laidi C, Bulteau S, et al.. Real world transcranial magnetic stimulation for major depression: A multisite, naturalistic, retrospective study. J Affect Disord. 2023, 326:26-35. 10.1016\/j.jad.2023.01.070","journal-title":"J Affect Disord"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1177\/0269881120922965","article-title":"Attenuation of antidepressive effects of transcranial magnetic stimulation in patients whose medication includes drugs for psychosis","volume":"34","author":"Hebel T","year":"2020","unstructured":"Hebel T, Abdelnaim M, Deppe M, Langguth B, Schecklmann M. Attenuation of antidepressive effects of transcranial magnetic stimulation in patients whose medication includes drugs for psychosis. J Psychopharmacol. 2020, 34:1119-24. 10.1177\/0269881120922965","journal-title":"J Psychopharmacol"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1002\/brb3.1275","article-title":"Concomitant medication use and clinical outcome of repetitive Transcranial Magnetic Stimulation (rTMS) treatment of Major Depressive Disorder","volume":"9","author":"Hunter AM","year":"2019","unstructured":"Hunter AM, Minzenberg MJ, Cook IA, et al.. Concomitant medication use and clinical outcome of repetitive Transcranial Magnetic Stimulation (rTMS) treatment of Major Depressive Disorder. Brain Behav. 2019, 9:e01275. 10.1002\/brb3.1275","journal-title":"Brain Behav"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1177\/0269881116675516","article-title":"Effect of antipsychotic pharmacotherapy on clinical outcomes of intermittent theta-burst stimulation for refractory depression","volume":"31","author":"Schulze L","year":"2017","unstructured":"Schulze L, Remington G, Giacobbe P, Kennedy SH, Blumberger DM, Daskalakis ZJ, Downar J. Effect of antipsychotic pharmacotherapy on clinical outcomes of intermittent theta-burst stimulation for refractory depression. J Psychopharmacol. 2017, 31:312-9. 10.1177\/0269881116675516","journal-title":"J Psychopharmacol"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1002\/da.22503","article-title":"A study of the pattern of response to rTMS treatment in depression","volume":"33","author":"Fitzgerald PB","year":"2016","unstructured":"Fitzgerald PB, Hoy KE, Anderson RJ, Daskalakis ZJ. A study of the pattern of response to rTMS treatment in depression. Depress Anxiety. 2016, 33:746-53. 10.1002\/da.22503","journal-title":"Depress Anxiety"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1007\/s00406-021-01287-3","article-title":"Antidepressant effect of repetitive transcranial magnetic stimulation is not impaired by intake of lithium or antiepileptic drugs","volume":"271","author":"Hebel T","year":"2021","unstructured":"Hebel T, Abdelnaim MA, Deppe M, et al.. Antidepressant effect of repetitive transcranial magnetic stimulation is not impaired by intake of lithium or antiepileptic drugs. Eur Arch Psychiatry Clin Neurosci. 2021, 271:1245-53. 10.1007\/s00406-021-01287-3","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1002\/da.23255","article-title":"Psychostimulant use and clinical outcome of repetitive transcranial magnetic stimulation treatment of major depressive disorder","volume":"39","author":"Wilke SA","year":"2022","unstructured":"Wilke SA, Johnson CL, Corlier J, Marder KG, Wilson AC, Pleman CM, Leuchter AF. Psychostimulant use and clinical outcome of repetitive transcranial magnetic stimulation treatment of major depressive disorder. Depress Anxiety. 2022, 39:397-406. 10.1002\/da.23255","journal-title":"Depress Anxiety"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1007\/s00406-020-01160-9","article-title":"Concomitant lorazepam use and antidepressive efficacy of repetitive transcranial magnetic stimulation in a naturalistic setting","volume":"271","author":"Deppe M","year":"2021","unstructured":"Deppe M, Abdelnaim M, Hebel T, Kreuzer PM, Poeppl TB, Langguth B, Schecklmann M. Concomitant lorazepam use and antidepressive efficacy of repetitive transcranial magnetic stimulation in a naturalistic setting. Eur Arch Psychiatry Clin Neurosci. 2021, 271:61-7. 10.1007\/s00406-020-01160-9","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1016\/j.brs.2020.02.022","article-title":"Benzodiazepine use and response to repetitive transcranial magnetic stimulation in Major Depressive Disorder","volume":"13","author":"Fitzgerald PB","year":"2020","unstructured":"Fitzgerald PB, Daskalakis ZJ, Hoy KE. Benzodiazepine use and response to repetitive transcranial magnetic stimulation in Major Depressive Disorder. Brain Stimul. 2020, 13:694-5. 10.1016\/j.brs.2020.02.022","journal-title":"Brain Stimul"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.2018.18091096","article-title":"rajectories of response to dorsolateral prefrontal rTMS in major depression: A THREE-D study","volume":"176","author":"Kaster TS","year":"2019","unstructured":"Kaster TS, Downar J, Vila-Rodriguez F, et al.. rajectories of response to dorsolateral prefrontal rTMS in major depression: A THREE-D study. Am J Psychiatry. 2019, 176:367-75. 10.1176\/appi.ajp.2018.18091096","journal-title":"Am J Psychiatry"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1186\/s12888-014-0342-4","article-title":"Repetitive transcranial magnetic stimulation as an augmentative strategy for treatment-resistant depression, a meta-analysis of randomized, double-blind and sham-controlled study","volume":"14","author":"Liu B","year":"2014","unstructured":"Liu B, Zhang Y, Zhang L, Li L. Repetitive transcranial magnetic stimulation as an augmentative strategy for treatment-resistant depression, a meta-analysis of randomized, double-blind and sham-controlled study. BMC Psychiatry. 2014, 14:342. 10.1186\/s12888-014-0342-4","journal-title":"BMC Psychiatry"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/238987-effects-of-concomitant-use-of-various-psychotropic-medications-on-the-treatment-response-to-transcranial-magnetic-stimulation-for-depression-a-literature-review","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,4]],"date-time":"2024-11-04T16:38:14Z","timestamp":1730738294000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/238987-effects-of-concomitant-use-of-various-psychotropic-medications-on-the-treatment-response-to-transcranial-magnetic-stimulation-for-depression-a-literature-review"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,4]]},"references-count":32,"URL":"https:\/\/doi.org\/10.7759\/cureus.72993","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,11,4]]}}}